Tamayo Louis Edward's Form 4 filing
Lexeo Therapeutics, Inc. (LXEO) · filed Jul 1, 2026
- Accession no.
- 0002083206-26-000005
- Filed
- Jul 1, 2026, 6:49 PM ET
- Trade date
- Jun 29-Jul 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $20.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tamayo Louis EdwardCIK 0002083206 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | AGrant or awardAcquired | +12,000 | $0.00 | $0 | 101,665 | Direct | |
| Jul 1, 2026 | Common Stock | SSaleDisposed | −4,641 | $4.49 | −$20,838.09 | 97,024 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.